The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II randomised study to evaluate the antitumour activity of roginolisib, a novel non-ATP competitive and allosteric modulator inhibiting PI3Kd, in patients with metastatic uveal melanoma (OCULE-01).
 
Paul Nathan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Immunocore; Ipsen; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sun Pharma
Speakers' Bureau - Bristol-Myers Squibb; Immunocore; Merck; MSD; Novartis
Research Funding - Immunocore (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Immunocore; MSD
 
Anna Maria Di Giacomo
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Immunocore; Immunocore; MSD Oncology; Pierre Fabre; Sanofi; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Josep Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Clovis Oncology; IDEAYA Biosciences; Immunocore; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Immunocore; Incyte; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Pfizer/EMD Serono
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche
 
Giusy Di Conza
Employment - iOnctura
Stock and Other Ownership Interests - iOnctura
 
Tracey Hammett
Employment - iOnctura
Stock and Other Ownership Interests - iOnctura
 
Paramjit Kaur
Employment - AstraZeneca; iOnctura
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - iOnctura
 
Karen Tonge
Employment - iOnctura
Stock and Other Ownership Interests - iOnctura
 
Lars van der Veen
Employment - iOnctura
Leadership - iOnctura
Stock and Other Ownership Interests - iOnctura
 
Michael Lahn
Employment - iOnctura
Leadership - iOnctura
Stock and Other Ownership Interests - Incyte; iOnctura